CDNA
Caredx
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: CDNA
- PE Ratio
As at Aug 27, 2026, the CDNA stock has a PE ratio of 24.35. This is based on the current EPS of $2.15 and the stock price of $52.36 per share.
CDNA PE ratio history
The mean historical PE ratio of Caredx over the last two years is 15.56. The current 24.35 P/E ratio is 56% higher than the historical average. In the past two years, CDNA's PE ratio peaked in the Dec 2024 quarter at 21.41, with a price of $21.41 and an EPS of $1. The Sep 2025 quarter marked the lowest point at 10.77, with a price of $14.54 and an EPS of $1.35.
Caredx PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | N/A | N/A | $18.84 | -$0.4 |
| 2024 | 21.41 | N/A | $21.41 | $1 |
| 2023 | N/A | N/A | $12 | -$3.54 |
| 2022 | N/A | N/A | $11.41 | -$1.44 |
| 2021 | N/A | N/A | $45.48 | -$0.59 |
| 2020 | N/A | N/A | $72.45 | -$0.4 |
| 2019 | N/A | N/A | $21.57 | -$0.52 |
| 2018 | N/A | N/A | $25.14 | -$1.31 |
| 2017 | N/A | N/A | $7.34 | -$2.38 |
| 2016 | N/A | N/A | $2.7 | -$2.39 |
| 2015 | N/A | N/A | $6.4 | -$1.16 |
| 2014 | 55.77 | N/A | $7.25 | $0.13 |
| 2013 | N/A | N/A | N/A | -$3.5 |
| 2012 | N/A | N/A | N/A | -$5.01 |
Caredx PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2026 | 13.26 | N/A | $28.5 | $2.15 |
| Mar 2026 | N/A | N/A | $17.36 | -$0.16 |
| Dec 2025 | N/A | N/A | $18.84 | -$0.4 |
| Sep 2025 | 10.77 | -38.28% | $14.54 | $1.35 |
| Jun 2025 | 17.45 | 16.96% | $19.54 | $1.12 |
| Mar 2025 | 14.92 | -30.31% | $17.75 | $1.19 |
| Dec 2024 | 21.41 | N/A | $21.41 | $1 |
| Sep 2024 | N/A | N/A | $31.23 | -$2.87 |
| Jun 2024 | N/A | N/A | $15.53 | -$3.1 |
| Mar 2024 | N/A | N/A | $10.59 | -$3.47 |
| Dec 2023 | N/A | N/A | $12 | -$3.54 |
| Sep 2023 | N/A | N/A | $7 | -$1.68 |
| Jun 2023 | N/A | N/A | $8.5 | -$1.57 |
| Mar 2023 | N/A | N/A | $9.14 | -$1.52 |
| Dec 2022 | N/A | N/A | $11.41 | -$1.44 |
CDNA Price vs fair value
CDNA average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, CDNA's PE ratio is above the 3, 5 and 10-year averages.
PE comparison
Caredx's P/E of 24.35 is below the Healthcare sector and the industry average. But in comparison with its Healthcare sector average of 24.42, Caredx's P/E is only 0.3% lower.
CDNA PE vs peers
Frequently asked questions
What is Caredx's PE ratio?
The price to earnings ratio for CDNA stock is 24.35 as of Aug 27, 2026.
What is the 3-year average PE ratio for Caredx (CDNA)?
The average PE ratio for CDNA stock over the past 3 years is 15.56.
What is the 5-year average PE ratio for Caredx (CDNA)?
The average PE ratio for CDNA stock over the past 5 years is 15.56.
What is the highest PE ratio for CDNA?
The current PE of 24.35 represents the highest historical value in the last two years.
How does the current PE ratio for CDNA compare to its historical average?
CDNA's current price to earnings ratio is 56% above its 2-year historical average.
How is CDNA's PE ratio calculated (Caredx PE ratio formula)?
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Aug 27, 2026), Caredx's stock price is $52.36. The earnings per share for the trailing twelve months (TTM) ending Jun 2026 is $2.15. Therefore, Caredx's PE ratio for today is 24.35. PE RATIO(24.35) = STOCK PRICE($52.36) / TTM EPS($2.15)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.